During a recent cabinet meeting, U.S. President Trump announced that the United States intends to take bold steps in the pharmaceutical industry. He proposed imposing tariffs as high as 200% on certain imported drugs, while also offering a one to one-and-a-half-year transition period for enterprises to adapt. Furthermore, he is contemplating an additional 50% surcharge on imported copper.